Evidence map›Paper›PMID 32066665›Full record

ArticleTranslational psychiatry2020

A truncating Aspm allele leads to a complex cognitive phenotype and region-specific reductions in parvalbuminergic neurons.

Lillian Garrett, Yoon Jeung Chang, Kristina M Niedermeier, Tamara Heermann, Wolfgang Enard, Helmut Fuchs, Valerie Gailus-Durner, Martin Hrabě de Angelis, Wieland B Huttner, Wolfgang Wurst and 1 more

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. The Parvalbumin Hypothesis of Autism Spectrum Disorder.Frontiers in cellular neuroscience · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Lillian GarrettInstitute of Developmental Genetics, Helmholtz Zentrum München, Neuherberg, Germany.ORCID http://orcid.org/0000-0003-4880-7076
Yoon Jeung ChangMax Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.
Kristina M NiedermeierInstitute of Developmental Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
Tamara HeermannInstitute of Developmental Genetics, Helmholtz Zentrum München, Neuherberg, Germany.ORCID http://orcid.org/0000-0003-1607-0727
Wolfgang EnardAnthropology and Human Genomics, Department of Biology II, Ludwig Maximilians University Munich, Martinsried, Germany.
Helmut FuchsGerman Mouse Clinic, Helmholtz Zentrum München, Neuherberg, Germany.ORCID http://orcid.org/0000-0002-5143-2677
Valerie Gailus-DurnerGerman Mouse Clinic, Helmholtz Zentrum München, Neuherberg, Germany.ORCID http://orcid.org/0000-0002-6076-0111
Martin Hrabě de AngelisGerman Mouse Clinic, Helmholtz Zentrum München, Neuherberg, Germany.ORCID http://orcid.org/0000-0002-7898-2353
Wieland B HuttnerMax Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.
Wolfgang WurstInstitute of Developmental Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
Sabine M HölterInstitute of Developmental Genetics, Helmholtz Zentrum München, Neuherberg, Germany. hoelter@helmholtz-muenchen.de.ORCID http://orcid.org/0000-0003-4878-5241
Helmholtz Zentrum München · DEMax Planck Institute of Molecular Cell Biology and Genetics · DEGerman Center for Neurodegenerative Diseases · DELudwig-Maximilians-Universität München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurodevelopmental disorders are heterogeneous and identifying shared genetic aetiologies and converging signalling pathways affected could improve disease diagnosis and treatment. Truncating mutations of the abnormal spindle-like microcephaly associated (ASPM) gene cause autosomal recessive primary microcephaly (MCPH) in humans. ASPM is a positive regulator of Wnt/β-Catenin signalling and controls symmetric to asymmetric cell division. This process balances neural progenitor proliferation with differentiation during embryogenesis, the malfunction of which could interfere with normal brain development. ASPM mutations may play a role also in other neurodevelopmental disorders, nevertheless, we lack the details of how or to what extent. We therefore assessed neurodevelopmental disease and circuit endophenotypes in mice with a truncating Aspm

Indexed as

Autism Spectrum DisorderNerve Tissue ProteinsAllelesAnimalsCalmodulin-Binding ProteinsCognitionHumansMiceMutationNeuronsPhenotypeASPM protein, humanASPM protein, mouseCalmodulin-Binding ProteinsNerve Tissue Proteins

Identifiers

PMID32066665
PMCPMC7026184
OpenAlexW3005797123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.